Julia C Ford
7PUBLICATIONS
53CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 11, 2024
Human cytomegalovirus UL18 prevents priming of MHC-E- and MHC-II-restricted CD8+ T cells.Daniel Malouli, Husam Taher, Mandana Mansouri
|Jun 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.Scott G Hansen, Meaghan H Hancock, Daniel Malouli
|Jul 06, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.Fredrik Barrenäs, Scott G Hansen, Lynn Law
|Mar 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.Marieke C Verweij, Scott G Hansen, Ravi Iyer
|Mar 26, 2021
Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy.Daniel Malouli, Scott G Hansen, Meaghan H Hancock
|Jul 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.Scott G Hansen, Emily E Marshall, Daniel Malouli
Pageof 2
Frequent Collaborators
6 joint publications
Daniel Malouli
6 joint publications
Scott G Hansen
6 joint publications
Michael K Axthelm
6 joint publications
David Morrow
6 joint publications
Paul T Edlefsen
6 joint publications
Louis J Picker
6 joint publications
Klaus Früh
5 joint publications
William J Bosche
4 joint publications
Jeffrey D Lifson
4 joint publications
Brian Berkemeier
